Drugs and pregnancy.
D000014:Abnormalities, Drug-Induced / Q000209:etiology*; D000700:Analgesics / Q000009:adverse effects; D000818:Animals; D000890:Anti-Infective Agents / Q000009:adverse effects; D000927:Anticonvulsants / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000009:adverse effects; D013956:Antithyroid Agents / Q000009:adverse effects; D001798:Blood Proteins / Q000378:metabolism; D003577:Cytochrome P-450 Enzyme System / Q000096:biosynthesis; D004074:Digitoxin / Q000009:adverse effects; D004232:Diuretics / Q000009:adverse effects; D005260:Female; D005333:Fetus / Q000187:drug effects / Q000378:metabolism; D005865:Gestational Age; D006728:Hormones / Q000009:adverse effects; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects; D007166:Immunosuppressive Agents / Q000009:adverse effects; D066298:In Vitro Techniques; D007231:Infant, Newborn; D008431:Maternal-Fetal Exchange / Q000187:drug effects; D009467:Neuromuscular Depolarizing Agents / Q000627:therapeutic use; D010276:Parasympatholytics / Q000009:adverse effects; D011247:Pregnancy / Q000187:drug effects*; D011485:Protein Binding; D051381:Rats; D011955:Receptors, Drug; D014116:Toxicology; D005719:gamma-Globulins / Q000009:adverse effects
D000700:Analgesics; D000890:Anti-Infective Agents; D000927:Anticonvulsants; D000970:Antineoplastic Agents; D013956:Antithyroid Agents; D001798:Blood Proteins; D004232:Diuretics; D006728:Hormones; D007004:Hypoglycemic Agents; D007166:Immunosuppressive Agents; D009467:Neuromuscular Depolarizing Agents; D010276:Parasympatholytics; D011955:Receptors, Drug; D005719:gamma-Globulins; D003577:Cytochrome P-450 Enzyme System; D004074:Digitoxin